Journal Article

SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouse

Yasmin Beazer-Barclay, Daniel B. Levy, Amy R. Moser, William F. Dove, Stanley R. Hamilton, Bert Vogelstein and Kenneth W. Kinzler

in Carcinogenesis

Volume 17, issue 8, pages 1757-1760
Published in print August 1996 | ISSN: 0143-3334
e-ISSN: 1460-2180 | DOI: https://dx.doi.org/10.1093/carcin/17.8.1757
SHORT COMMUNICATION: Sulindac suppresses tumorigenesis in the Min mouse

More Like This

Show all results sharing this subject:

  • Clinical Cytogenetics and Molecular Genetics

GO

Show Summary Details

Preview

The Min mouse provides a genetically defined model for inherited and sporadic forms of human colorectal tumorigenesis. To test the suitability of this model for the evaluation and optimization of chemopreventive agents, we examined the effects of sulindac on tumorigenesis in Min mice as this compound can inhibit colorectal tumorigenesis in human familial adenomatous polyposis patients. Treatment of Min mice with sulindac in their drinking water (84 mg/1) or diet (167 and 334 p.p.m.) resulted in a significantly decreased average tumor load. The conservation of sulindac activity in the Min mouse provides an opportunity to explore the mechanism of sulindac suppression as well as to test other potential chemopreventive agents.

Journal Article.  0 words. 

Subjects: Clinical Cytogenetics and Molecular Genetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.